BR9915214A - Combinações contendo um beta-agonista e umagente anti-diabético adicional - Google Patents
Combinações contendo um beta-agonista e umagente anti-diabético adicionalInfo
- Publication number
- BR9915214A BR9915214A BR9915214-2A BR9915214A BR9915214A BR 9915214 A BR9915214 A BR 9915214A BR 9915214 A BR9915214 A BR 9915214A BR 9915214 A BR9915214 A BR 9915214A
- Authority
- BR
- Brazil
- Prior art keywords
- agonist
- beta
- diabetic agent
- additional anti
- combinations containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9824789.3A GB9824789D0 (en) | 1998-11-11 | 1998-11-11 | Novel method of treatment |
GBGB9824790.1A GB9824790D0 (en) | 1998-11-11 | 1998-11-11 | Novel method of treatment |
GBGB9824791.9A GB9824791D0 (en) | 1998-11-11 | 1998-11-11 | Novel methods of treatment |
PCT/GB1999/003755 WO2000027434A1 (en) | 1998-11-11 | 1999-11-11 | Combinations comprising a beta-agonist and a further antidiabetic agent |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9915214A true BR9915214A (pt) | 2001-12-18 |
Family
ID=27269550
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9915214-2A BR9915214A (pt) | 1998-11-11 | 1999-11-11 | Combinações contendo um beta-agonista e umagente anti-diabético adicional |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP1128845A1 (tr) |
JP (1) | JP2002529430A (tr) |
KR (1) | KR20010075698A (tr) |
CN (1) | CN1332638A (tr) |
AU (1) | AU766928B2 (tr) |
BR (1) | BR9915214A (tr) |
CA (1) | CA2350062A1 (tr) |
CZ (1) | CZ20011655A3 (tr) |
HK (1) | HK1041201A1 (tr) |
HU (1) | HUP0104388A3 (tr) |
IL (1) | IL143004A0 (tr) |
NO (1) | NO20012300L (tr) |
PL (1) | PL348154A1 (tr) |
TR (1) | TR200101336T2 (tr) |
WO (1) | WO2000027434A1 (tr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2007201729B2 (en) * | 1999-12-23 | 2010-02-25 | Novartis Ag | Use of hypoglycemic agent for treating impaired glucose metabolism |
AU777776B2 (en) | 1999-12-23 | 2004-10-28 | Novartis Ag | Use of hypoglycemic agent for treating impaired glucose metabolism |
WO2001047509A2 (en) * | 1999-12-24 | 2001-07-05 | Smithkline Beecham P.L.C. | Composition for the treatment diabetes mellitus containing an insuline sensitizer and agent used in the treatment of cardiac conditions |
EP1258253A1 (en) * | 2000-01-28 | 2002-11-20 | Asahi Kasei Kabushiki Kaisha | Novel remedies with the use of beta3 agonist |
AU2001252575A1 (en) * | 2000-04-28 | 2001-11-12 | Asahi Kasei Kabushiki Kaisha | Novel tricyclic compounds |
AU2001252573A1 (en) * | 2000-04-28 | 2001-11-12 | Asahi Kasei Kabushiki Kaisha | Novel substituted tricyclic compounds |
WO2006132196A1 (ja) * | 2005-06-08 | 2006-12-14 | Asahi Kasei Pharma Corporation | β3作動薬を含有する新規な医薬 |
US11053255B2 (en) | 2015-06-22 | 2021-07-06 | Georgetown University | Synthesis of mahanine and related compounds |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR0170416B1 (ko) * | 1990-02-09 | 1999-02-18 | 로버트 에이. 아미테이지 | 고혈압 치료를 위한 인슐린 증감제의 용도 |
ZA967892B (en) * | 1995-09-21 | 1998-03-18 | Lilly Co Eli | Selective β3 adrenergic agonists. |
ATE251608T1 (de) * | 1996-01-10 | 2003-10-15 | Asahi Chemical Ind | Neue trizyklische verbindungen und arzneimittelzusammensetzungen die diese enthalten |
-
1999
- 1999-11-11 CA CA002350062A patent/CA2350062A1/en not_active Abandoned
- 1999-11-11 EP EP99954217A patent/EP1128845A1/en not_active Withdrawn
- 1999-11-11 CZ CZ20011655A patent/CZ20011655A3/cs unknown
- 1999-11-11 PL PL99348154A patent/PL348154A1/xx not_active Application Discontinuation
- 1999-11-11 CN CN99815382A patent/CN1332638A/zh active Pending
- 1999-11-11 BR BR9915214-2A patent/BR9915214A/pt not_active Application Discontinuation
- 1999-11-11 JP JP2000580663A patent/JP2002529430A/ja not_active Withdrawn
- 1999-11-11 WO PCT/GB1999/003755 patent/WO2000027434A1/en not_active Application Discontinuation
- 1999-11-11 HU HU0104388A patent/HUP0104388A3/hu unknown
- 1999-11-11 TR TR2001/01336T patent/TR200101336T2/tr unknown
- 1999-11-11 KR KR1020017005958A patent/KR20010075698A/ko not_active Application Discontinuation
- 1999-11-11 IL IL14300499A patent/IL143004A0/xx unknown
- 1999-11-11 AU AU10634/00A patent/AU766928B2/en not_active Ceased
-
2001
- 2001-05-10 NO NO20012300A patent/NO20012300L/no not_active Application Discontinuation
-
2002
- 2002-02-08 HK HK02101022.8A patent/HK1041201A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
NO20012300D0 (no) | 2001-05-10 |
JP2002529430A (ja) | 2002-09-10 |
CA2350062A1 (en) | 2000-05-18 |
TR200101336T2 (tr) | 2001-11-21 |
WO2000027434A1 (en) | 2000-05-18 |
EP1128845A1 (en) | 2001-09-05 |
KR20010075698A (ko) | 2001-08-09 |
CZ20011655A3 (cs) | 2002-06-12 |
AU766928B2 (en) | 2003-10-23 |
NO20012300L (no) | 2001-07-03 |
PL348154A1 (en) | 2002-05-06 |
HK1041201A1 (zh) | 2002-07-05 |
CN1332638A (zh) | 2002-01-23 |
HUP0104388A3 (en) | 2002-12-28 |
IL143004A0 (en) | 2002-04-21 |
AU1063400A (en) | 2000-05-29 |
HUP0104388A2 (hu) | 2002-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG127714A1 (en) | Method of treating metabolic disorders, especiallydiabetes, or a disease or condition associated wi th diabetes | |
MXPA02012763A (es) | Combinaciones de inhibidores de dipeptidil peptidasa iv y otros agentes antidiabeticos para el tratamiento de diabetes mellitus. | |
BG104060A (en) | Diabetes treatment with thiazolyidindion and methformine | |
EA200101089A1 (ru) | Новый способ лечения | |
NZ504258A (en) | Exendin 3 and 4 agonist compounds for the treatment of diabetes | |
ES2187659T3 (es) | Tratamiento de la diabetes mellitus de tipo ii con agonistas de amilina. | |
CA2346119A1 (en) | A method of inducing or enhancing chondrogenesis with extracellular matrix containing gdf-5 | |
CA2002859A1 (en) | Method of treating epithelial disorders | |
BR0208727A (pt) | Eritropoietina melhorando a toxicidade in vivo induzida por quimioterapia | |
BR9810445A (pt) | Tratamento de diabete com tiazolidinadiona, secretagogo de insulina e diguanida | |
BR9915214A (pt) | Combinações contendo um beta-agonista e umagente anti-diabético adicional | |
BR9810444A (pt) | Tratamento de diabete com rosiglitazona e insulina | |
BR9810292A (pt) | Tratamento de diabete com tiazolidinadiona, secretagogo de insulina e inibidor de alfa-glicosidase | |
UY25103A1 (es) | Composición para el tratamiento de diabetes mellitus | |
BR9810186A (pt) | Tratamento de diabete com tiazolidinadiona e inibidor de alfa-glicosidade | |
BR9810142A (pt) | Tratamento de diabete com tiazolidinadiona e sulfonil-uréia | |
KR970061245A (ko) | 프로제스테론 및 에스트로젠 작동약을 사용한, 뼈 손실 예방용 약학 조성물 | |
WO2001045714A3 (en) | Formulations of adenosine a1 agonists | |
BR9915284A (pt) | Método de tratamento | |
KR920702676A (ko) | 신규 입체이성질체 | |
WO2001047509A3 (en) | Composition for the treatment diabetes mellitus containing an insuline sensitizer and agent used in the treatment of cardiac conditions | |
JPS6485990A (en) | Antihypertestoeronemia agent | |
BR9912144A (pt) | Uso de absorsão de glicose como promotor para redução de danos de pós-isquemia do coração | |
ECSP982592A (es) | Nuevo metodo de tratamiento v | |
BR9912117A (pt) | Uso de estimulador de captação de glicose para reduzir a apoptose |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PRESENTE PEDIDO DE ACORDO COM OS ARTIGOS 8O E 25 DA LPI. |
|
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |